Press releases
- Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08
- Nevro to Present at Truist Securities MedTech Conference
- Nevro to Present at BofA Securities 2024 Healthcare Conference
- Nevro Reports First-Quarter 2024 Financial Results
- Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024
More ▼
Key statistics
As of last trade Nevro Corp (1N7:FRA) traded at 7.70, 4.05% above its 52-week low of 7.40, set on Jun 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 7.70 |
---|---|
High | 7.70 |
Low | 7.70 |
Bid | 7.70 |
Offer | 7.80 |
Previous close | 7.70 |
Average volume | 0.00 |
---|---|
Shares outstanding | 36.73m |
Free float | 35.33m |
P/E (TTM) | -- |
Market cap | 307.79m USD |
EPS (TTM) | -2.28 USD |
Data delayed at least 15 minutes, as of Jul 04 2024 07:03 BST.
More ▼